* Hank Brown, CU president emeritus, announces retirement from university
   
* Faculty Council: Proposed early retirement incentive could be greater
   
* Tuition benefit all in the family at UCCS
   
* Five questions for Jason Katzman
   
* People
   
* Forum
   
* Did you know...
 
 NEWS FROM THE CU SYSTEM
 
  CU-BOULDER
  CU-Boulder contingent makes trek to Copenhagen climate conference
 
  UCCS
  University to program downtown art gallery
 
  UC DENVER
  Gift from Wal-Mart will help small Colorado communities go green
 
  ANSCHUTZ MEDICAL CAMPUS
  School of Pharmacy researcher receives funding from Michael J. Fox Foundation
 
  TECH TRANSFER
  Soligenix options CU vaccine technology
 
   Home
   Newsletter Archive
 
Download Newsleter in PDF
 
Share your thoughts
  FORUM
Share your opinion in a Letter to the Editor

CONTACT US
Send your thoughts and suggestions for the Newsletter
   
   
   
   
   
   
   

News from the CU system - Anschutz Medical Campus

School of Pharmacy researcher receives funding from Michael J. Fox Foundation


Photo courtesy of Isabella Muturi Sauve
Manisha Patel, Ph.D.

The Michael J. Fox Foundation for Parkinson's Research recently announced $1.5 million in total awards to six research teams, including an associate professor from University of Colorado Denver's School of Pharmacy, who are working to develop potentially disease-modifying therapies for Parkinson's disease (PD). The funding was awarded under the Novel Approaches to Drug Discovery for Parkinson's disease program made possible by funding from Elan Corporation, a neuroscience-based biotechnology company.

"Current therapeutic approaches to treat PD are associated with serious adverse effects and fail to provide long-term control of this relentlessly progressive disease," said Manisha Patel, Ph.D., an associate professor at the School of Pharmacy, and recipient of $300,000 of the $1.5 million awarded. "There is an urgent need for novel classes of therapeutic agents for the treatment of PD. Neuroprotective catalytic antioxidant compounds that are orally active and capable of penetrating the brain hold tremendous therapeutic potential for the treatment of PD."

Patel's laboratory has been involved in the development of catalytic antioxidants for the treatment of neuronal disorders for more than a decade. If the project is successful, potential drug candidates can be further developed by Elan for treatment of Parkinson's.

Awardees under Novel Approaches, a program that is an important component of the foundation's strategy of providing resources to underfunded areas of the drug development pipeline, include both academic and industry scientists. Of the six awardees, four teams including Patel are developing technologies to prevent the degeneration of dopaminergic neurons, the main type of cell affected in Parkinson's, by focusing on the reduction of oxidative stress and the inhibition of a protein associated with cell death. The remaining two will target the protein alpha-synuclein, whose clumping is a hallmark of Parkinson's pathology.

This is the second time in 2009 that the Michael J. Fox Foundation has provided funding to UC Denver researchers. Curt Freed, M.D., received a grant in August to further investigate his discovery that a drug called phenylbutyrate can prevent brain deterioration in animal models of Parkinson's by turning on a protective gene.

 

 

Bookmark - Print - Share

 
Previous Anschutz Medical Campus Stories

12/02/2009
New UC Denver program puts high school grads on pathway to med school

11/18/2009
Award of $577,000 will aid study of tuberculosis treatment

11/11/2009
Depression Center works to establish national network

11/04/2009
School of Medicine to take part in nationwide study of blood pressure

10/28/2009
College of Nursing expands offerings in Western Regional Graduate Program

10/21/2009
Study: Tanning associated with moles in very light-skinned children

10/14/2009
When the laboratory meets the studio

10/07/2009
When the laboratory meets the studio

09/30/2009
Cancer Center scientists win $870,000 ARRA Challenge Grant

09/23/2009
Cancer Center scientists win $870,000 ARRA Challenge Grant

09/16/2009
University of Colorado Cancer Center wins National Cancer Institute grant

09/02/2009
Ground broken on planned VA medical center

08/19/2009
SOM, state labor department to manage training facility

08/06/2009
Pulmonary hypertension drug helps former smokers

07/23/2009
Breast cancer researcher receives gift from Avon